Prioritising patients over profits
Australia’s first ‘for-benefit’ pharmaceutical company directing 100% of profits to patient support & medical research…
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Australia’s first ‘for-benefit’ pharmaceutical company directing 100% of profits to patient support & medical research…
One in three cancer patients experiences a significant financial burden due to the cost of…
COSA ASM: Delays in diagnosis, variations in treatment and lack of participation in clinical trials may…
Cells communicate with other cells in our bodies by sending and receiving signals. Cancer can…
COSA ASM: Australian researchers are conducting multiple clinical trials to determine the effectiveness of radiotherapy…
By Jill Margo – AFR. Almost 100,000 Australian men are living with little or no sex life as…
Aspirin has been shown to decrease the risk of colorectal cancer and possibly other cancers.…
A new template published by the American Society for Radiation Oncology (ASTRO) standardises and streamlines…
USC researchers have developed a mathematical model to forecast metastatic breast cancer survival rates using…
By Rajah Supramaniam, Program Manager at the Research Division of the Cancer Council New South Wales. COSA…